Regulation of chemokine receptor signaling
趋化因子受体信号传导的调节
基本信息
- 批准号:10622915
- 负责人:
- 金额:$ 25.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:A kinase anchoring proteinAddressAutomobile DrivingBiochemicalBiological AssayBiophysicsCXC ChemokinesCell Culture TechniquesCessation of lifeConfocal MicroscopyDiseaseEmbryonic DevelopmentFamilyFluorescenceG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGoalsKnowledgeLabelLigationMalignant NeoplasmsModelingMolecularPhysiological ProcessesPlayPrognosisReceptor SignalingRegulationResearchRoleSignal TransductionTherapeuticTranslatingbeta-arrestinchemokine receptordrug discoveryhuman diseaseimmune functioninnovationlive cell imagingnovelreceptorreceptor bindingreconstitutionstem cellsstructural determinantstherapeutic development
项目摘要
PROJECT SUMMARY
G protein-coupled receptor (GPCR) signaling plays an essential role in many physiological processes and is also
involved in many human diseases, yet the mechanisms governing GPCR signaling remain poorly understood.
The goal of the proposed research is to further our mechanistic understanding of GPCR signaling. The model
GPCR receptor we study is the therapeutically relevant C-X-C chemokine receptor 4 (CXCR4). CXCR4 signaling
is important for embryogenesis, immune function and stem cell regulation, among other functions. In addition,
CXCR4 signaling is involved in several human diseases, including cancer. CXCR4 is aberrantly expressed in
many cancers and its expression correlates with poor prognosis. This is mainly because CXCR4 signaling
contributes to metastatic disease, the reason for most cancer related deaths. Yet the mechanisms governing
CXCR4 signaling remain poorly understood. To achieve our goal, we will address two main questions: 1. What
are the biophysical and structural determinants driving GPCR signaling by β-arrestins via non-GPCR binding
partners? 2. What are the roles of PKCd and A-kinase anchoring proteins (AKAPs) in compartmentalized
heterologous regulation of GPCR signaling? To address these questions, we will mainly use cell culture models
and reconstitution assays using several complimentary integrative approaches including biophysical,
biochemical, proximity ligation, multi-labeling fluorescence confocal microscopy, live cell imaging, and signaling
assays. We believe our research is significant because we expect to define new concepts that apply broadly
across the GPCR family, which will provide an advanced explanation of the mechanisms driving GPCR signaling.
Our research hold the promise to translate new knowledge into innovative drug discovery efforts to modulate
GPCR signaling therapeutically.
项目概要
G 蛋白偶联受体 (GPCR) 信号在许多生理过程中发挥着重要作用,并且
GPCR 与许多人类疾病有关,但人们对 GPCR 信号传导的机制仍知之甚少。
本研究的目的是加深我们对 GPCR 信号传导机制的理解。型号
我们研究的 GPCR 受体是治疗相关的 C-X-C 趋化因子受体 4 (CXCR4)。 CXCR4信号传导
对于胚胎发生、免疫功能和干细胞调节等功能很重要。此外,
CXCR4 信号传导涉及多种人类疾病,包括癌症。 CXCR4 异常表达于
许多癌症及其表达与不良预后相关。这主要是因为CXCR4信号传导
导致转移性疾病,这是大多数癌症相关死亡的原因。然而,治理机制
CXCR4 信号传导仍然知之甚少。为了实现我们的目标,我们将解决两个主要问题: 1. 什么
是通过非 GPCR 结合驱动 β-arrestins 发出 GPCR 信号的生物物理和结构决定因素
合作伙伴? 2. PKCd和A激酶锚定蛋白(AKAPs)在区室化中的作用是什么?
GPCR 信号传导的异源调控?为了解决这些问题,我们将主要使用细胞培养模型
和重构测定使用几种互补的综合方法,包括生物物理、
生化、邻近连接、多标记荧光共聚焦显微镜、活细胞成像和信号传导
化验。我们相信我们的研究意义重大,因为我们期望定义广泛适用的新概念
整个 GPCR 家族,这将为驱动 GPCR 信号传导的机制提供高级解释。
我们的研究有望将新知识转化为创新药物发现工作,以调节
GPCR 信号传导治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adriano Marchese其他文献
Adriano Marchese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adriano Marchese', 18)}}的其他基金
FASEB SRC: The G Protein-coupled Receptor Kinases and Arrestins Conference: Key Modulators of Signal Transduction
FASEB SRC:G 蛋白偶联受体激酶和抑制蛋白会议:信号转导的关键调节剂
- 批准号:
10464336 - 财政年份:2022
- 资助金额:
$ 25.03万 - 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
- 批准号:
10795393 - 财政年份:2021
- 资助金额:
$ 25.03万 - 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
- 批准号:
10646415 - 财政年份:2021
- 资助金额:
$ 25.03万 - 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
- 批准号:
10317369 - 财政年份:2021
- 资助金额:
$ 25.03万 - 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
- 批准号:
10471999 - 财政年份:2021
- 资助金额:
$ 25.03万 - 项目类别:
Role of beta-arrestins in chemokine receptor signaling
β-抑制蛋白在趋化因子受体信号传导中的作用
- 批准号:
10300898 - 财政年份:2014
- 资助金额:
$ 25.03万 - 项目类别:
Role of beta-arrestins in chemokine receptor signaling
β-抑制蛋白在趋化因子受体信号传导中的作用
- 批准号:
10391496 - 财政年份:2014
- 资助金额:
$ 25.03万 - 项目类别:
Role of beta-arrestins in G protein-coupled receptor sorting and signaling
β-抑制蛋白在 G 蛋白偶联受体分选和信号转导中的作用
- 批准号:
8877924 - 财政年份:2014
- 资助金额:
$ 25.03万 - 项目类别:
Role of beta-arrestins in chemokine receptor signaling
β-抑制蛋白在趋化因子受体信号传导中的作用
- 批准号:
10386287 - 财政年份:2014
- 资助金额:
$ 25.03万 - 项目类别:
Role of beta-arrestins in G protein-coupled receptor sorting and signaling
β-抑制蛋白在 G 蛋白偶联受体分选和信号转导中的作用
- 批准号:
8632561 - 财政年份:2014
- 资助金额:
$ 25.03万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 25.03万 - 项目类别:
Research Grant














{{item.name}}会员




